Laboratory Co. of America Holdings (NYSE:LH) Shares Sold by State of New Jersey Common Pension Fund D

State of New Jersey Common Pension Fund D decreased its holdings in Laboratory Co. of America Holdings (NYSE:LHFree Report) by 5.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 46,648 shares of the medical research company’s stock after selling 2,653 shares during the quarter. State of New Jersey Common Pension Fund D owned 0.05% of Laboratory Co. of America worth $9,379,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. First Horizon Advisors Inc. raised its holdings in Laboratory Co. of America by 1.7% in the second quarter. First Horizon Advisors Inc. now owns 2,843 shares of the medical research company’s stock worth $686,000 after purchasing an additional 47 shares during the period. Neuberger Berman Group LLC grew its stake in Laboratory Co. of America by 0.6% in the 4th quarter. Neuberger Berman Group LLC now owns 7,834 shares of the medical research company’s stock valued at $1,845,000 after buying an additional 48 shares during the last quarter. SP Asset Management LLC increased its position in Laboratory Co. of America by 0.3% during the 2nd quarter. SP Asset Management LLC now owns 14,901 shares of the medical research company’s stock worth $3,596,000 after buying an additional 50 shares during the period. Essex Financial Services Inc. raised its position in shares of Laboratory Co. of America by 1.9% in the second quarter. Essex Financial Services Inc. now owns 2,669 shares of the medical research company’s stock valued at $644,000 after buying an additional 50 shares in the last quarter. Finally, Guardian Wealth Management Inc. lifted its position in Laboratory Co. of America by 1.0% during the first quarter. Guardian Wealth Management Inc. now owns 5,379 shares of the medical research company’s stock worth $1,418,000 after purchasing an additional 52 shares during the period. Hedge funds and other institutional investors own 89.37% of the company’s stock.

Laboratory Co. of America Stock Performance

NYSE LH opened at $222.59 on Monday. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.36 and a quick ratio of 1.20. The stock has a market capitalization of $18.90 billion, a PE ratio of 29.76 and a beta of 1.04. Laboratory Co. of America Holdings has a 1-year low of $174.20 and a 1-year high of $234.09. The business has a 50 day simple moving average of $223.49 and a two-hundred day simple moving average of $213.20.

Laboratory Co. of America Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 13th. Shareholders of record on Tuesday, February 27th will be given a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, February 26th. This represents a $2.88 annualized dividend and a yield of 1.29%. Laboratory Co. of America’s dividend payout ratio (DPR) is currently 38.50%.

Insiders Place Their Bets

In other news, CAO Peter J. Wilkinson sold 1,384 shares of the firm’s stock in a transaction that occurred on Thursday, November 16th. The stock was sold at an average price of $210.71, for a total value of $291,622.64. Following the completion of the sale, the chief accounting officer now directly owns 2,087 shares of the company’s stock, valued at approximately $439,751.77. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other Laboratory Co. of America news, EVP Der Vaart Sandra D. Van sold 259 shares of the stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $222.06, for a total value of $57,513.54. Following the sale, the executive vice president now owns 7,637 shares in the company, valued at $1,695,872.22. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CAO Peter J. Wilkinson sold 1,384 shares of the business’s stock in a transaction dated Thursday, November 16th. The shares were sold at an average price of $210.71, for a total transaction of $291,622.64. Following the completion of the sale, the chief accounting officer now directly owns 2,087 shares of the company’s stock, valued at $439,751.77. The disclosure for this sale can be found here. Corporate insiders own 0.65% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on LH. TheStreet upgraded Laboratory Co. of America from a “c+” rating to a “b-” rating in a research report on Thursday, January 18th. Mizuho decreased their price target on Laboratory Co. of America from $257.00 to $230.00 and set a “buy” rating for the company in a report on Tuesday, October 31st. Barclays started coverage on shares of Laboratory Co. of America in a research report on Wednesday, January 3rd. They set an “equal weight” rating and a $222.00 target price on the stock. Evercore ISI initiated coverage on Laboratory Co. of America in a report on Friday. They issued an “in-line” rating and a $240.00 price target on the stock. Finally, JPMorgan Chase & Co. boosted their price objective on Laboratory Co. of America from $259.00 to $261.00 and gave the stock an “overweight” rating in a report on Friday, November 17th. Five analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $241.86.

Check Out Our Latest Stock Report on Laboratory Co. of America

About Laboratory Co. of America

(Free Report)

Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics and Labcorp Drug Development.

Featured Stories

Want to see what other hedge funds are holding LH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Laboratory Co. of America Holdings (NYSE:LHFree Report).

Institutional Ownership by Quarter for Laboratory Co. of America (NYSE:LH)

Receive News & Ratings for Laboratory Co. of America Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Laboratory Co. of America and related companies with MarketBeat.com's FREE daily email newsletter.